cardiovascular benefits of glp 1 agonists Effects Glucagon-Like Peptide-1 Receptor Cardiovascular benefits of glucagon-like peptide-1
Description
In addition, trials on human and mice showed GLP-1 receptor agonists benefits in heart failure, endothelial lining and,myocardial ischemia.First, heart failure clinical trials on human showed at New York Heart Association involved diabetic patients with stage 3-4 heart failure better response with Glp-1 continuous infusion over 12 weeks duration in the form of better left ventricular ejection fraction and 6 minute walk over 48 hours trial of GLP-1 infusion in nondiabetic patients with stage 2-3 heart failure
Alicic, J.J
doi: 10.1111/cup.12246
Individual tolerance varies more than the medication choice
The move from blanket cessation to risk-adjusted continuation reflects improved understanding of therapeutic value, promoting shared decision-making and equity in care
By comparison, the risk of death among sleep apnea patients was 1% for those on a GLP-1 versus 2.5% for those who werent
